A Crosstalk between the Cannabinoid Receptors and Nociceptin Receptors in Colitis—Clinical Implications
Inflammatory bowel diseases (IBD) refer to a group of gastrointestinal (GI) disorders with complex pathogenesis characterized by chronic intestinal inflammation with a variety of symptoms. Cannabinoid and nociceptin opioid receptors (NOPs) and their ligands are widely distributed in the GI tract. Th...
Main Authors: | Maria Wołyniak, Ewa Małecka-Wojciesko, Marta Zielińska, Adam Fabisiak |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-11-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/11/22/6675 |
Similar Items
-
Spotlight on Nociceptin/Orphanin FQ Receptor in the Treatment of Pain
by: Amal El Daibani, et al.
Published: (2022-01-01) -
Interactions between the Nociceptin and Toll-like Receptor Systems
by: Lan Zhang, et al.
Published: (2022-03-01) -
Traumatic Brain Injury Induces Nociceptin/Orphanin FQ and Nociceptin Opioid Peptide Receptor Expression within 24 Hours
by: Omar N. Al Yacoub, et al.
Published: (2024-01-01) -
Buprenorphine reduces methamphetamine intake and drug seeking behavior via activating nociceptin/orphanin FQ peptide receptor in rats
by: Fangmin Wang, et al.
Published: (2022-10-01) -
Role of Endo-opioid and Endo-cannabinoid Systems in Migraine and Medication-overuse Headache
by: Gökçen Hatipoğlu, et al.
Published: (2022-12-01)